Overview
- Shares have climbed roughly 41% so far in January after a 61% decline in the fourth quarter of 2025, including a 29.2% drop in December.
- NuScale continues to raise equity after shareholders approved expanding authorized shares to 662 million from 332 million, heightening dilution concerns.
- Fluor, the company’s largest shareholder, plans to sell its entire stake by the end of the second quarter of 2026.
- The company still has no first commercial reactor sale; Romania’s RoPower is evaluating up to six units with a purchasing decision expected in late 2026 or early 2027, and NuScale is earning consulting revenue during the assessment.
- Bank of America upgraded the stock to neutral on Jan. 9 with a $28 price target, and sector sentiment improved after Meta announced multigigawatt nuclear deals with Oklo and Vistra.